[go: up one dir, main page]

MX2010007950A - Formas salinas de un derivado de 6-fluoro-1,2-dihidro-2-oxo-3h-ind ol-3-ilideno, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. - Google Patents

Formas salinas de un derivado de 6-fluoro-1,2-dihidro-2-oxo-3h-ind ol-3-ilideno, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.

Info

Publication number
MX2010007950A
MX2010007950A MX2010007950A MX2010007950A MX2010007950A MX 2010007950 A MX2010007950 A MX 2010007950A MX 2010007950 A MX2010007950 A MX 2010007950A MX 2010007950 A MX2010007950 A MX 2010007950A MX 2010007950 A MX2010007950 A MX 2010007950A
Authority
MX
Mexico
Prior art keywords
indol
oxo
fluoro
manufacture
salt forms
Prior art date
Application number
MX2010007950A
Other languages
English (en)
Inventor
Werner Rall
Christian Kulinna
Waldemar Pfrengle
Ulrike Werthmann
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40383691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010007950(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MX2010007950A publication Critical patent/MX2010007950A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a formas salinas del compuesto ácido 4-[(Z)-[[4-[(dimetilamino)metil]fenil]amino](6-fluoro-1,2-di hidro-2-oxo-3H-indol-3-ilideno)metil]-bencenopropanoico, que son adecuadas para el desarrollo farmacéutico y a un procedimiento para su elaboración.
MX2010007950A 2008-01-25 2009-01-22 Formas salinas de un derivado de 6-fluoro-1,2-dihidro-2-oxo-3h-ind ol-3-ilideno, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. MX2010007950A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08150660 2008-01-25
PCT/EP2009/000378 WO2009092581A1 (en) 2008-01-25 2009-01-22 Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same

Publications (1)

Publication Number Publication Date
MX2010007950A true MX2010007950A (es) 2010-08-04

Family

ID=40383691

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010007950A MX2010007950A (es) 2008-01-25 2009-01-22 Formas salinas de un derivado de 6-fluoro-1,2-dihidro-2-oxo-3h-ind ol-3-ilideno, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.

Country Status (20)

Country Link
US (1) US20110130437A1 (es)
EP (1) EP2238108B1 (es)
JP (1) JP2011510032A (es)
KR (1) KR20100109968A (es)
CN (1) CN101925577A (es)
AR (1) AR070250A1 (es)
AU (1) AU2009207862A1 (es)
BR (1) BRPI0908509A2 (es)
CA (1) CA2712388A1 (es)
CL (1) CL2009000152A1 (es)
DK (1) DK2238108T3 (es)
ES (1) ES2394239T3 (es)
IL (1) IL206934A0 (es)
MX (1) MX2010007950A (es)
NZ (1) NZ586867A (es)
PL (1) PL2238108T3 (es)
RU (1) RU2010135198A (es)
TW (1) TW200944502A (es)
WO (1) WO2009092581A1 (es)
ZA (1) ZA201004821B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ586760A (en) * 2008-01-25 2011-12-22 Boehringer Ingelheim Int Process for the preparation of 4-[(Z)-[[4-[(dimethylamino)methyl]phenyl]amino](6-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-benzenepropanoic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1115704E (pt) * 1998-09-25 2003-11-28 Boehringer Ingelheim Pharma Novas indolinonas substituidas com accao inibidora sobre varias quinases e complexos ciclina/cdk
GB9904933D0 (en) * 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US7169936B2 (en) * 2002-07-23 2007-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
DE10233366A1 (de) * 2002-07-23 2004-02-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel
PE20040701A1 (es) * 2002-07-23 2004-11-30 Boehringer Ingelheim Pharma Derivados de indolinona sustituidos en posicion 6 y su preparacion como medicamentos
PE20061155A1 (es) * 2004-12-24 2006-12-16 Boehringer Ingelheim Int Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas

Also Published As

Publication number Publication date
CA2712388A1 (en) 2009-07-30
ZA201004821B (en) 2011-03-30
JP2011510032A (ja) 2011-03-31
AU2009207862A1 (en) 2009-07-30
DK2238108T3 (da) 2012-10-15
CN101925577A (zh) 2010-12-22
AR070250A1 (es) 2010-03-25
IL206934A0 (en) 2010-12-30
BRPI0908509A2 (pt) 2015-08-18
RU2010135198A (ru) 2012-02-27
ES2394239T3 (es) 2013-01-23
TW200944502A (en) 2009-11-01
KR20100109968A (ko) 2010-10-11
EP2238108A1 (en) 2010-10-13
US20110130437A1 (en) 2011-06-02
CL2009000152A1 (es) 2010-07-23
WO2009092581A1 (en) 2009-07-30
PL2238108T3 (pl) 2013-01-31
EP2238108B1 (en) 2012-08-29
NZ586867A (en) 2012-05-25

Similar Documents

Publication Publication Date Title
WO2007141283A3 (en) Salts and crystalline salt forms of an 2-indolinone derivative
NO20084783L (no) Syntese av acylaminoalkenylenamider nyttige som substans P antagonister
MY184008A (en) Aryl pyridine as aldosterone synthase inhibitors
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
TN2012000125A1 (en) Substituted carbamoylmethylamino acetic acid derivatives as novel nep inhibitors
MY173448A (en) Phenyl and benzodioxinly substituted indazoles derivatives
JO3297B1 (ar) تركيبات و طرق لتعديل fxr
EA201270520A1 (ru) Новые соединения, эффективные в качестве ингибиторов ксантиноксидазы, способ их получения и содержащая их фармацевтическая композиция
MX2009005357A (es) Derivados de hidantoina usados como inhibidores de metaloproteinasas de matriz.
EA201300250A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
TW200833657A (en) Novel process
EA201291217A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ
EA200600323A1 (ru) γd-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
WO2010150211A3 (en) Use of derivatives of indoles for the treatment of cancer
MX2011012199A (es) Derivados de benzoxazolona como inhibidores de la sintasa de aldosterona.
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
MX2012001411A (es) Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico.
EA200801893A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
MX2012000685A (es) Compuesto de 3-fenoximetilpirrolidina.
MX2010009876A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexanocarboxilico por medio del derivado de ciclohexanocarboxamida correspondiente.
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
MX2007007025A (es) Nuevos derivados de hidantoina como inhibidores de metaloproteinasa.
MX2010007950A (es) Formas salinas de un derivado de 6-fluoro-1,2-dihidro-2-oxo-3h-ind ol-3-ilideno, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
GEP20094745B (en) Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
FA Abandonment or withdrawal